nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—HTR2C—choroid plexus—malignant glioma	0.125	0.165	CbGeAlD
Mesoridazine—DRD3—telencephalic ventricle—malignant glioma	0.0659	0.0868	CbGeAlD
Mesoridazine—HTR2A—choroid plexus—malignant glioma	0.0628	0.0827	CbGeAlD
Mesoridazine—HTR2C—telencephalic ventricle—malignant glioma	0.0367	0.0483	CbGeAlD
Mesoridazine—HTR2A—cerebellar cortex—malignant glioma	0.0316	0.0416	CbGeAlD
Mesoridazine—HTR1A—telencephalic ventricle—malignant glioma	0.0309	0.0406	CbGeAlD
Mesoridazine—DRD2—telencephalic ventricle—malignant glioma	0.0279	0.0367	CbGeAlD
Mesoridazine—HTR2A—pons—malignant glioma	0.0224	0.0294	CbGeAlD
Mesoridazine—HTR2A—vertebral column—malignant glioma	0.0222	0.0292	CbGeAlD
Mesoridazine—HTR2A—telencephalic ventricle—malignant glioma	0.0184	0.0242	CbGeAlD
Mesoridazine—HTR2A—pineal body—malignant glioma	0.016	0.021	CbGeAlD
Mesoridazine—HTR6—telencephalon—malignant glioma	0.0152	0.0201	CbGeAlD
Mesoridazine—Trifluoperazine—CALY—malignant glioma	0.0114	0.407	CrCbGaD
Mesoridazine—HTR2C—brainstem—malignant glioma	0.00992	0.0131	CbGeAlD
Mesoridazine—HTR2A—endothelium—malignant glioma	0.00987	0.013	CbGeAlD
Mesoridazine—CHRM2—telencephalon—malignant glioma	0.00914	0.012	CbGeAlD
Mesoridazine—HTR2A—blood vessel—malignant glioma	0.00911	0.012	CbGeAlD
Mesoridazine—DRD3—central nervous system—malignant glioma	0.009	0.0118	CbGeAlD
Mesoridazine—HTR2C—telencephalon—malignant glioma	0.00881	0.0116	CbGeAlD
Mesoridazine—HTR6—central nervous system—malignant glioma	0.00866	0.0114	CbGeAlD
Mesoridazine—HTR1A—brainstem—malignant glioma	0.00835	0.011	CbGeAlD
Mesoridazine—DRD2—brainstem—malignant glioma	0.00755	0.00994	CbGeAlD
Mesoridazine—HTR1A—telencephalon—malignant glioma	0.00741	0.00976	CbGeAlD
Mesoridazine—DRD2—retina—malignant glioma	0.00728	0.00958	CbGeAlD
Mesoridazine—DRD3—brain—malignant glioma	0.00714	0.0094	CbGeAlD
Mesoridazine—HTR2C—medulla oblongata—malignant glioma	0.00692	0.00911	CbGeAlD
Mesoridazine—HTR6—brain—malignant glioma	0.00688	0.00905	CbGeAlD
Mesoridazine—DRD2—telencephalon—malignant glioma	0.0067	0.00882	CbGeAlD
Mesoridazine—KCNH2—telencephalon—malignant glioma	0.0066	0.00869	CbGeAlD
Mesoridazine—HTR2C—midbrain—malignant glioma	0.00632	0.00833	CbGeAlD
Mesoridazine—HTR2C—spinal cord—malignant glioma	0.00617	0.00812	CbGeAlD
Mesoridazine—HTR2A—embryo—malignant glioma	0.00543	0.00715	CbGeAlD
Mesoridazine—HTR1A—midbrain—malignant glioma	0.00532	0.00701	CbGeAlD
Mesoridazine—HRH1—telencephalon—malignant glioma	0.00529	0.00696	CbGeAlD
Mesoridazine—HTR1A—spinal cord—malignant glioma	0.00519	0.00684	CbGeAlD
Mesoridazine—CHRM2—central nervous system—malignant glioma	0.00519	0.00684	CbGeAlD
Mesoridazine—KCNH2—medulla oblongata—malignant glioma	0.00519	0.00683	CbGeAlD
Mesoridazine—HTR2C—central nervous system—malignant glioma	0.00501	0.00659	CbGeAlD
Mesoridazine—HTR2A—brainstem—malignant glioma	0.00498	0.00655	CbGeAlD
Mesoridazine—DRD2—midbrain—malignant glioma	0.00481	0.00633	CbGeAlD
Mesoridazine—HTR2A—retina—malignant glioma	0.0048	0.00632	CbGeAlD
Mesoridazine—KCNH2—midbrain—malignant glioma	0.00474	0.00624	CbGeAlD
Mesoridazine—KCNH2—spinal cord—malignant glioma	0.00462	0.00609	CbGeAlD
Mesoridazine—CYP2D6—brainstem—malignant glioma	0.00453	0.00597	CbGeAlD
Mesoridazine—HTR2A—telencephalon—malignant glioma	0.00442	0.00582	CbGeAlD
Mesoridazine—HTR1A—central nervous system—malignant glioma	0.00421	0.00555	CbGeAlD
Mesoridazine—CHRM2—brain—malignant glioma	0.00412	0.00543	CbGeAlD
Mesoridazine—HTR1A—cerebellum—malignant glioma	0.00412	0.00542	CbGeAlD
Mesoridazine—CYP2D6—telencephalon—malignant glioma	0.00402	0.0053	CbGeAlD
Mesoridazine—HTR2C—brain—malignant glioma	0.00397	0.00523	CbGeAlD
Mesoridazine—DRD2—central nervous system—malignant glioma	0.00381	0.00501	CbGeAlD
Mesoridazine—KCNH2—central nervous system—malignant glioma	0.00375	0.00494	CbGeAlD
Mesoridazine—DRD2—cerebellum—malignant glioma	0.00372	0.0049	CbGeAlD
Mesoridazine—KCNH2—cerebellum—malignant glioma	0.00367	0.00483	CbGeAlD
Mesoridazine—HTR2A—medulla oblongata—malignant glioma	0.00347	0.00457	CbGeAlD
Mesoridazine—HTR1A—brain—malignant glioma	0.00334	0.0044	CbGeAlD
Mesoridazine—Ethopropazine—BCHE—malignant glioma	0.00322	0.115	CrCbGaD
Mesoridazine—HTR2A—midbrain—malignant glioma	0.00317	0.00418	CbGeAlD
Mesoridazine—HTR2A—spinal cord—malignant glioma	0.0031	0.00407	CbGeAlD
Mesoridazine—DRD2—brain—malignant glioma	0.00302	0.00398	CbGeAlD
Mesoridazine—HRH1—central nervous system—malignant glioma	0.00301	0.00396	CbGeAlD
Mesoridazine—KCNH2—brain—malignant glioma	0.00298	0.00392	CbGeAlD
Mesoridazine—Eletriptan—PTGS1—malignant glioma	0.0028	0.1	CrCbGaD
Mesoridazine—Perphenazine—CYP2C18—malignant glioma	0.00265	0.0947	CrCbGaD
Mesoridazine—Triflupromazine—BCHE—malignant glioma	0.00264	0.0944	CrCbGaD
Mesoridazine—HTR2A—central nervous system—malignant glioma	0.00251	0.00331	CbGeAlD
Mesoridazine—HTR2A—cerebellum—malignant glioma	0.00245	0.00323	CbGeAlD
Mesoridazine—HRH1—brain—malignant glioma	0.00239	0.00314	CbGeAlD
Mesoridazine—CYP2D6—central nervous system—malignant glioma	0.00229	0.00301	CbGeAlD
Mesoridazine—CYP2D6—cerebellum—malignant glioma	0.00224	0.00294	CbGeAlD
Mesoridazine—Promethazine—CYP2B6—malignant glioma	0.00201	0.072	CrCbGaD
Mesoridazine—HTR2A—brain—malignant glioma	0.00199	0.00262	CbGeAlD
Mesoridazine—Perphenazine—CYP2B6—malignant glioma	0.00196	0.0703	CrCbGaD
Mesoridazine—CYP2D6—brain—malignant glioma	0.00182	0.00239	CbGeAlD
Mesoridazine—Chlorpromazine—BCHE—malignant glioma	0.00127	0.0455	CrCbGaD
Mesoridazine—DRD2—Signaling Pathways—KDR—malignant glioma	4.22e-05	0.000199	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CASP3—malignant glioma	4.21e-05	0.000198	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IL2—malignant glioma	4.21e-05	0.000198	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CAV1—malignant glioma	4.2e-05	0.000198	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CAV1—malignant glioma	4.19e-05	0.000197	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—BRAF—malignant glioma	4.16e-05	0.000196	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—KDR—malignant glioma	4.15e-05	0.000195	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—KDR—malignant glioma	4.14e-05	0.000195	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—BRAF—malignant glioma	4.14e-05	0.000195	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CAV1—malignant glioma	4.12e-05	0.000194	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—KDR—malignant glioma	4.07e-05	0.000192	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—FN1—malignant glioma	4.06e-05	0.000191	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—F2—malignant glioma	4.06e-05	0.000191	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—AKT2—malignant glioma	4.05e-05	0.000191	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—EGFR—malignant glioma	4.03e-05	0.00019	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—AKT2—malignant glioma	4.03e-05	0.00019	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—PIK3CA—malignant glioma	4.01e-05	0.000189	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—BAD—malignant glioma	4.01e-05	0.000189	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—EGFR—malignant glioma	4.01e-05	0.000189	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MDM2—malignant glioma	4e-05	0.000188	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—F2—malignant glioma	3.99e-05	0.000188	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—FN1—malignant glioma	3.99e-05	0.000188	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—F2—malignant glioma	3.99e-05	0.000188	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—FN1—malignant glioma	3.99e-05	0.000188	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—RAF1—malignant glioma	3.98e-05	0.000188	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MMP9—malignant glioma	3.98e-05	0.000187	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NOTCH1—malignant glioma	3.97e-05	0.000187	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GSTP1—malignant glioma	3.97e-05	0.000187	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—PTEN—malignant glioma	3.96e-05	0.000186	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—BAD—malignant glioma	3.95e-05	0.000186	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—ERBB2—malignant glioma	3.94e-05	0.000186	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—BAD—malignant glioma	3.94e-05	0.000185	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—F2—malignant glioma	3.92e-05	0.000185	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—FN1—malignant glioma	3.92e-05	0.000185	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NOTCH1—malignant glioma	3.91e-05	0.000184	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NOTCH1—malignant glioma	3.9e-05	0.000184	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CD80—malignant glioma	3.89e-05	0.000183	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—PIK3CB—malignant glioma	3.89e-05	0.000183	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PIK3CD—malignant glioma	3.89e-05	0.000183	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PIK3CG—malignant glioma	3.89e-05	0.000183	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—APC—malignant glioma	3.89e-05	0.000183	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—BAD—malignant glioma	3.88e-05	0.000182	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PIK3CD—malignant glioma	3.87e-05	0.000182	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CAT—malignant glioma	3.87e-05	0.000182	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—AKT1—malignant glioma	3.86e-05	0.000182	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—PIK3CA—malignant glioma	3.85e-05	0.000181	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—EGF—malignant glioma	3.84e-05	0.000181	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	3.84e-05	0.000181	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—PIK3CA—malignant glioma	3.83e-05	0.00018	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CD80—malignant glioma	3.83e-05	0.00018	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—APC—malignant glioma	3.82e-05	0.00018	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PIK3CG—malignant glioma	3.82e-05	0.00018	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CD80—malignant glioma	3.82e-05	0.00018	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PTPN11—malignant glioma	3.82e-05	0.00018	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PIK3CG—malignant glioma	3.81e-05	0.00018	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—APC—malignant glioma	3.81e-05	0.00018	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—KRAS—malignant glioma	3.81e-05	0.000179	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—KRAS—malignant glioma	3.79e-05	0.000178	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—EGF—malignant glioma	3.78e-05	0.000178	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—EGF—malignant glioma	3.77e-05	0.000177	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CD80—malignant glioma	3.76e-05	0.000177	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PTPN11—malignant glioma	3.76e-05	0.000177	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—APC—malignant glioma	3.75e-05	0.000177	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	3.75e-05	0.000177	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PTPN11—malignant glioma	3.75e-05	0.000176	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CXCL8—malignant glioma	3.74e-05	0.000176	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—FGF2—malignant glioma	3.72e-05	0.000175	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—EGF—malignant glioma	3.71e-05	0.000175	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—FGF2—malignant glioma	3.71e-05	0.000174	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PTPN11—malignant glioma	3.69e-05	0.000174	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—BRAF—malignant glioma	3.65e-05	0.000172	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—NCOR1—malignant glioma	3.65e-05	0.000172	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—AKT1—malignant glioma	3.61e-05	0.00017	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—BRAF—malignant glioma	3.59e-05	0.000169	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—BRAF—malignant glioma	3.59e-05	0.000169	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CASP3—malignant glioma	3.58e-05	0.000168	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—VEGFA—malignant glioma	3.58e-05	0.000168	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IL2—malignant glioma	3.57e-05	0.000168	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AKT2—malignant glioma	3.55e-05	0.000167	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—STAT3—malignant glioma	3.54e-05	0.000167	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—EGFR—malignant glioma	3.54e-05	0.000167	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—BRAF—malignant glioma	3.53e-05	0.000166	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—PIK3CA—malignant glioma	3.5e-05	0.000165	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AKT2—malignant glioma	3.5e-05	0.000165	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AKT2—malignant glioma	3.49e-05	0.000164	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MDM2—malignant glioma	3.48e-05	0.000164	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—EGFR—malignant glioma	3.48e-05	0.000164	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—PIK3CA—malignant glioma	3.48e-05	0.000164	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—EGFR—malignant glioma	3.48e-05	0.000164	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—RAF1—malignant glioma	3.47e-05	0.000163	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MDM2—malignant glioma	3.47e-05	0.000163	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—RAF1—malignant glioma	3.46e-05	0.000163	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—ERBB2—malignant glioma	3.44e-05	0.000162	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AKT2—malignant glioma	3.43e-05	0.000162	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—EGFR—malignant glioma	3.42e-05	0.000161	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—ERBB2—malignant glioma	3.42e-05	0.000161	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PIK3CD—malignant glioma	3.42e-05	0.000161	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	3.39e-05	0.00016	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	3.38e-05	0.000159	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MMP9—malignant glioma	3.38e-05	0.000159	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PIK3CB—malignant glioma	3.37e-05	0.000159	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—PTEN—malignant glioma	3.36e-05	0.000158	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PIK3CD—malignant glioma	3.36e-05	0.000158	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PIK3CD—malignant glioma	3.35e-05	0.000158	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—KRAS—malignant glioma	3.34e-05	0.000157	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—PIK3CA—malignant glioma	3.33e-05	0.000157	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	3.32e-05	0.000156	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	3.3e-05	0.000155	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—KRAS—malignant glioma	3.29e-05	0.000155	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MYC—malignant glioma	3.29e-05	0.000155	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—KRAS—malignant glioma	3.28e-05	0.000155	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—AKT1—malignant glioma	3.28e-05	0.000154	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—FGF2—malignant glioma	3.27e-05	0.000154	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	3.27e-05	0.000154	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CXCL8—malignant glioma	3.26e-05	0.000153	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CXCL8—malignant glioma	3.24e-05	0.000153	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—KRAS—malignant glioma	3.23e-05	0.000152	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—FGF2—malignant glioma	3.22e-05	0.000151	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—EGFR—malignant glioma	3.22e-05	0.000151	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—FGF2—malignant glioma	3.21e-05	0.000151	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—FGF2—malignant glioma	3.16e-05	0.000149	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	3.15e-05	0.000148	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	3.13e-05	0.000147	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CASP3—malignant glioma	3.12e-05	0.000147	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IL2—malignant glioma	3.11e-05	0.000147	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CASP3—malignant glioma	3.1e-05	0.000146	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IL2—malignant glioma	3.1e-05	0.000146	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	3.07e-05	0.000145	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MDM2—malignant glioma	3.06e-05	0.000144	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—RAF1—malignant glioma	3.05e-05	0.000144	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—KRAS—malignant glioma	3.04e-05	0.000143	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—VEGFA—malignant glioma	3.04e-05	0.000143	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	3.02e-05	0.000142	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—ERBB2—malignant glioma	3.02e-05	0.000142	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	3.02e-05	0.000142	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MDM2—malignant glioma	3.01e-05	0.000142	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—STAT3—malignant glioma	3.01e-05	0.000142	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MDM2—malignant glioma	3e-05	0.000141	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—RAF1—malignant glioma	3e-05	0.000141	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—RAF1—malignant glioma	2.99e-05	0.000141	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	2.98e-05	0.00014	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CAV1—malignant glioma	2.98e-05	0.00014	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	2.97e-05	0.00014	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	2.97e-05	0.00014	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—ERBB2—malignant glioma	2.96e-05	0.000139	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MDM2—malignant glioma	2.96e-05	0.000139	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MMP9—malignant glioma	2.95e-05	0.000139	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—RAF1—malignant glioma	2.95e-05	0.000139	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MMP9—malignant glioma	2.93e-05	0.000138	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PTEN—malignant glioma	2.93e-05	0.000138	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	2.93e-05	0.000138	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	2.92e-05	0.000138	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PTEN—malignant glioma	2.91e-05	0.000137	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	2.91e-05	0.000137	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	2.88e-05	0.000135	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CXCL8—malignant glioma	2.86e-05	0.000135	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—AKT1—malignant glioma	2.86e-05	0.000135	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	2.84e-05	0.000134	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	2.81e-05	0.000133	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CXCL8—malignant glioma	2.81e-05	0.000132	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MYC—malignant glioma	2.79e-05	0.000132	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—PIK3CA—malignant glioma	2.79e-05	0.000131	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	2.76e-05	0.00013	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	2.76e-05	0.00013	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CASP3—malignant glioma	2.74e-05	0.000129	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL2—malignant glioma	2.73e-05	0.000129	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—EGFR—malignant glioma	2.73e-05	0.000129	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	2.72e-05	0.000128	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	2.71e-05	0.000128	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.71e-05	0.000128	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TP53—malignant glioma	2.7e-05	0.000127	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CASP3—malignant glioma	2.69e-05	0.000127	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL2—malignant glioma	2.69e-05	0.000127	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CASP3—malignant glioma	2.69e-05	0.000127	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL2—malignant glioma	2.68e-05	0.000126	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	2.67e-05	0.000126	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—VEGFA—malignant glioma	2.65e-05	0.000125	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CASP3—malignant glioma	2.65e-05	0.000125	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL2—malignant glioma	2.64e-05	0.000124	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	2.63e-05	0.000124	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—STAT3—malignant glioma	2.62e-05	0.000123	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PPARG—malignant glioma	2.62e-05	0.000123	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—STAT3—malignant glioma	2.61e-05	0.000123	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MMP9—malignant glioma	2.59e-05	0.000122	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—KRAS—malignant glioma	2.58e-05	0.000122	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PTEN—malignant glioma	2.57e-05	0.000121	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MMP9—malignant glioma	2.55e-05	0.00012	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MMP9—malignant glioma	2.54e-05	0.00012	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PTEN—malignant glioma	2.53e-05	0.000119	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PTEN—malignant glioma	2.53e-05	0.000119	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—AKT1—malignant glioma	2.51e-05	0.000118	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MMP9—malignant glioma	2.5e-05	0.000118	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PTEN—malignant glioma	2.49e-05	0.000117	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	2.47e-05	0.000116	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—AKT1—malignant glioma	2.46e-05	0.000116	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MYC—malignant glioma	2.43e-05	0.000115	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	2.42e-05	0.000114	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MYC—malignant glioma	2.42e-05	0.000114	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.38e-05	0.000112	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—EGFR—malignant glioma	2.38e-05	0.000112	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—PIK3CA—malignant glioma	2.37e-05	0.000112	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—EGFR—malignant glioma	2.37e-05	0.000112	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—VEGFA—malignant glioma	2.32e-05	0.000109	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—STAT3—malignant glioma	2.3e-05	0.000108	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TP53—malignant glioma	2.29e-05	0.000108	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	2.29e-05	0.000108	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—VEGFA—malignant glioma	2.28e-05	0.000107	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—AKT1—malignant glioma	2.28e-05	0.000107	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—STAT3—malignant glioma	2.26e-05	0.000107	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—STAT3—malignant glioma	2.26e-05	0.000106	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—KRAS—malignant glioma	2.25e-05	0.000106	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	2.24e-05	0.000106	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—KRAS—malignant glioma	2.24e-05	0.000105	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—STAT3—malignant glioma	2.22e-05	0.000105	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MYC—malignant glioma	2.14e-05	0.000101	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MYC—malignant glioma	2.1e-05	9.9e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MYC—malignant glioma	2.1e-05	9.88e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—EGFR—malignant glioma	2.09e-05	9.84e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.08e-05	9.78e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	2.07e-05	9.73e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MYC—malignant glioma	2.07e-05	9.72e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PTGS2—malignant glioma	2.06e-05	9.69e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—EGFR—malignant glioma	2.06e-05	9.69e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	2.06e-05	9.68e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—EGFR—malignant glioma	2.05e-05	9.66e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—EGFR—malignant glioma	2.02e-05	9.51e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TP53—malignant glioma	2e-05	9.41e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TP53—malignant glioma	1.99e-05	9.36e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—KRAS—malignant glioma	1.98e-05	9.3e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—KRAS—malignant glioma	1.94e-05	9.15e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—KRAS—malignant glioma	1.94e-05	9.13e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—AKT1—malignant glioma	1.94e-05	9.12e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—KRAS—malignant glioma	1.91e-05	8.98e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	1.81e-05	8.54e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PTEN—malignant glioma	1.79e-05	8.45e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	1.79e-05	8.41e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	1.78e-05	8.39e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TP53—malignant glioma	1.76e-05	8.26e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	1.75e-05	8.25e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TP53—malignant glioma	1.73e-05	8.13e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TP53—malignant glioma	1.72e-05	8.11e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TP53—malignant glioma	1.7e-05	7.98e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—AKT1—malignant glioma	1.69e-05	7.95e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—AKT1—malignant glioma	1.68e-05	7.91e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AKT1—malignant glioma	1.48e-05	6.98e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.46e-05	6.87e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AKT1—malignant glioma	1.46e-05	6.85e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AKT1—malignant glioma	1.43e-05	6.74e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.27e-05	5.96e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—AKT1—malignant glioma	1.03e-05	4.87e-05	CbGpPWpGaD
